Congestive Heart Failure Drugs Market Size 2023-2028 - PowerPoint PPT Presentation

About This Presentation
Title:

Congestive Heart Failure Drugs Market Size 2023-2028

Description:

Presently, the increasing global geriatric population, which is highly susceptible to diabetes and chronic cardiovascular diseases, represents one of the major factors positively influencing the market Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: Visit the following link: E-mail: sales@imarcgroup.com Contact: +91-120-415-5099 – PowerPoint PPT presentation

Number of Views:0
Slides: 13
Provided by: IMARC
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Congestive Heart Failure Drugs Market Size 2023-2028


1
Global Congestive Heart Failure Drugs Market
Research and Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Congestive Heart Failure Drugs Market
Research Report According to the latest report
by IMARC Group, titled Congestive Heart Failure
Drugs Market Global Industry Trends, Share,
Size, Growth, Opportunity and Forecast 2023-2028
the global congestive heart failure drugs market
reached a strong growth in 2022.  Congestive
heart failure is a medical condition that affects
the pumping ability of the heart muscle. It is
generally caused by hypertension, coronary artery
disease, diabetes, obesity, and excessive alcohol
consumption. Its symptoms include shortness of
breath while lying down, weakness, fatigue,
swelling in the abdomen, feet, and ankles,
frequent urination at night, nausea, and
difficulty in concentration. It can be prevented
by maintaining a healthy weight, staying
physically active, and controlling blood pressure
and glycemic levels. Besides this, it is
controlled using various prescribed drugs that
help prevent blood clots, expand blood vessels,
strengthen the contractions of the heart, and
improve heart functioning. At present, ACE
inhibitors, vasodilators, digitalis glycosides,
diuretics, and beta-blockers are some of the most
prescribed congestive heart failure drugs.
Amongst these, ACE inhibitors prevent the
formation of angiotensin, which causes blood
vessels to constrict, and beta blockers block the
actions of certain chemicals. Request Free
Sample Report https//www.imarcgroup.com/congesti
ve-heart-failure-drugs-market/requestsample
4
Report Description and Highlights
Report Description

Global Congestive Heart Failure Drugs Market
Trends Presently, the increasing global
geriatric population, which is highly susceptible
to diabetes and chronic cardiovascular diseases,
represents one of the major factors positively
influencing the market. In addition, excessive
smoking and drinking of alcoholic beverages,
coupled with unhealthy dietary habits of
individuals, increases the risks of heart
problems, which is catalyzing the demand for
congestive heart failure drugs across the globe.
This, coupled with the rising occurrence of heart
problems due to obesity and lack of physical
activity, is currently strengthening the growth
of the market. Furthermore, the increasing
awareness among individuals about the benefits of
early diagnosis and treatment of heart disease is
creating a positive outlook for the market. Apart
from this, the escalating demand for effective
drugs and treatment and their approval from
authorized agencies offer lucrative growth
opportunities to the leading market players.
Moreover, initiatives undertaken by governments
of various countries to improve healthcare
infrastructure and provide optimal care to
patients are contributing to the growth of the
market. Additionally, the expansion of pharmacies
in hospitals and residential areas and the
burgeoning e-commerce industry providing easy
availability of medicines at affordable rates and
the facility of secured online payment methods
are expected to propel the growth of the
market. Looking forward, the market value is
projected to reach a strong growth during the
forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Drug Class Insights AC
E Inhibitors Angiotensin 2 Receptor Bloc
kers Beta Blockers Diuretics
Aldosterone Antagonists
Inotropes Others Route of Adm
inistration Insights Oral Int
ravenous Distribution Channel Insights
Hospital Pharmacies Retail Pharmacies
Online Pharmacies

6
Report Description and Highlights
Report Description
Regional Insights North America
United States Canada
Asia Pacific China
Japan India
South Korea Austral
ia Indonesia O
thers Europe Germany
France United K
ingdom Italy S
pain Russia Ot
hers

7
Report Description and Highlights
Report Description
Latin America Brazil
Mexico Others
Middle East and Africa
Note We are updating our reports, If you want
latest primary and secondary data (2023-2028)
with Cost Module, Business Strategy, Distribution
Channel, etc. Click request free sample report.

8
Report Description and Highlights
Report Description
  • Competitive Landscape with Key Players
  • Bayer AG Boehringer Ingelheim International GmbH (
    C.H. Boehringer Sohn Ag Co. KG)
    Novartis AG Kindly note that this only represents
    a partial list of companies the complete list has
    been provided in the report
  • View Full Report with TOC List of Figure
    https//www.imarcgroup.com/congestive-heart-failur
    e-drugs-market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us
Write a Comment
User Comments (0)
About PowerShow.com